T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRK
376
DELISTED
WestRock Company
WRK
| $183M | 0.03% |
5,923,063
+619,458
| +12% | +$24.5M |
|
|
ETRN
377
CALL
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $183M | 0.03% |
+244,400
| New | +$2.04M |
|
378
Waters Corp
WAT
$41.2B
| $182M | 0.03% |
676,175
-159,161
| -19% | -$50.8M |
|
379
PNC Financial Services
PNC
$102B
| $182M | 0.03% |
1,219,884
-12,193,831
| -91% | -$1.98B |
|
380
Kohl's
KSS
$2.18B
| $182M | 0.03% |
7,235,995
+230,204
| +3% | +$6.71M |
|
381
Colgate-Palmolive
CL
$74.5B
| $182M | 0.03% |
2,585,890
+79,153
| +3% | +$6.21M |
|
382
Prothena Corp
PRTA
$477M
| $181M | 0.03% |
2,981,941
-2,983,847
| -50% | -$94.3M |
|
383
RTX Corp
RTX
$295B
| $180M | 0.03% |
2,202,577
-5,905
| -0.3% | -$534K |
|
384
NovoCure
NVCR
$2.04B
| $180M | 0.03% |
2,371,986
+40,619
| +2% | +$3.17M |
|
|
BDXB
385
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| – | – |
-3,888,470
| Closed | -$195M |
|
386
VeriSign
VRSN
$25.9B
| $179M | 0.03% |
1,031,808
-1,391,017
| -57% | -$257M |
|
387
McKesson
MCK
$101B
| $179M | 0.03% |
526,872
-31,847
| -6% | -$11.1M |
|
388
Terreno Realty
TRNO
$7.55B
| $176M | 0.03% |
3,318,116
-4,219,097
| -56% | -$254M |
|
389
Tidewater
TDW
$4.52B
| $175M | 0.03% |
8,078,871
+501,582
| +7% | +$10.7M |
|
390
Camden Property Trust
CPT
$11.1B
| $173M | 0.03% |
1,447,982
-683,147
| -32% | -$91.2M |
|
391
Apollo Global Management
APO
$82.6B
| $173M | 0.03% |
3,710,524
-4,169,671
| -53% | -$229M |
|
|
FRC
392
DELISTED
First Republic Bank
FRC
| $171M | 0.03% |
1,310,302
+818,703
| +167% | +$126M |
|
393
Emerson Electric
EMR
$90.1B
| $170M | 0.03% |
2,322,717
+329,047
| +17% | +$27.3M |
|
394
BioNTech
BNTX
$23.2B
| $169M | 0.03% |
1,256,309
-591,626
| -32% | -$90.4M |
|
395
United Rentals
URI
$69.8B
| $166M | 0.03% |
615,729
+365,935
| +146% | +$107M |
|
396
ResMed
RMD
$32.8B
| $165M | 0.03% |
757,315
-92,325
| -11% | -$21M |
|
397
Bruker
BRKR
$9.04B
| $165M | 0.03% |
3,107,985
-16,366,764
| -84% | -$978M |
|
398
Campbell Soup
CPB
$6.93B
| $165M | 0.03% |
3,496,275
-1,580,335
| -31% | -$77.5M |
|
399
Mohawk Industries
MHK
$9.45B
| $159M | 0.03% |
1,739,969
-7,764
| -0.4% | -$901K |
|
|
PDCO
400
DELISTED
Patterson Companies, Inc.
PDCO
| $157M | 0.03% |
6,536,277
-4,188,162
| -39% | -$120M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.